In Treatment for Cocaine Use Disorder?
Researchers at Virginia Commonwealth University are investigating an FDA-approved medication that may help reduce cocaine use in individuals who are already receiving treatment. Join our research study today!
Conducted in Richmond, VA
18-60 Years Old
Eligible for an MRI
Fast Facts
In Treatment For Cocaine Use Disorder
Study Background
During this study, our researchers aim to evaluate if transdermal Rotigotine, an FDA-approved medication, in combination with individual or group therapy, helps individuals currently in treatment for cocaine use disorder reduce cocaine use.

Receiving Rotigotine as a treatment (in addition to other treatments) may also improve cognitive function in individuals receiving therapy for cocaine use disorder, helping them retain concepts better and maintain goals in recovery.

Further research on cocaine use disorder treatments and join our study today!
Additional Information